Alembic Pharmaceuticals has informed that their Associate Company, Rhizen Pharmaceuticals SA has released a Press Release announcing that the USFDA has granted Fast Track Designation for RP6530 (tenalisib).
The above information is a part of company’s filings submitted to BSE.